What is Aurinia Pharmaceuticals's deferred tax assets?

Aurinia Pharmaceuticals (AUPH) reported deferred tax assets of $166.92M in Q1 2026.

What does deferred tax assets mean?

Represents future tax benefits arising from temporary differences between the book value of assets/liabilities and their tax basis, or from carry-forward tax losses. These assets are realized when the firm generates sufficient taxable income to offset these differences. It serves as an indicator of future tax savings potential.

Aurinia Pharmaceuticals AUPH Deferred Tax Assets

Deferred Tax Assets at other companies

Rogers CorporationROG

$67.8M+2.1%

ANI PharmaceuticalsANIP

$66.56M-24.8%

Kiniksa Pharmaceuticals International, plcKNSA

$193.63M-7.0%

LQD

Liquidia CorporationLQDA

$873K—

ALN

Alnylam PharmaceuticalsALNY

$116.96M+9.1%

Ligand PharmaceuticalsLGND

$8.47M+1,452%

Other financials

Income statement

See full

Revenue$77.7M+24.4%

Gross profit$71.2M+32.1%

Operating income$41.4M+89.6%

Net income$34.4M+47.2%

EPS (diluted)$0.25+56.3%

Balance sheet

See full

Cash & equivalents$41.0M-38.3%

Total debt$85.2M-7.9%

Total equity$567.6M+62.1%

Total assets$724.0M+43.4%

Cash flow

See full

Operating cash flow$32.6M+2,405%

Valuation

See full

Market cap$2.3B+78.5%

Enterprise value$2.34B+78.3%

P/E7.7×-24.6×

P/S7.7×+2.5×

Profitability

See full

Gross margin89.7%+1.5pp

Operating margin41.7%+29.4pp

Net margin100%+83.9pp

Returns & leverage

See full

Return on equity65%+53.8pp

Debt / equity0.2×-0.1×

Current ratio5.5×-0.4×

Where this comes from

Reported directly by Aurinia Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeTaxAssetsNet.

The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aurinia Pharmaceuticals's deferred tax assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Aurinia Pharmaceuticals's deferred tax assets?: Aurinia Pharmaceuticals (AUPH) reported deferred tax assets of $166.92M in Q1 2026.
What does deferred tax assets mean?: Represents future tax benefits arising from temporary differences between the book value of assets/liabilities and their tax basis, or from carry-forward tax losses. These assets are realized when the firm generates sufficient taxable income to offset these differences. It serves as an indicator of future tax savings potential.